Add to watchlist

Athersys Inc (ATHX)

ATHX Stock Chart
Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic product candidates in multiple disease areas in the United States. Its product pipeline includes MultiStem, a nonembryonic stem cell product candidate for the treatment of multiple disease indications. The company also develops orally active pharmaceutical products for the treatment of central nervous system disorders, such as narcolepsy, excessive daytime sleepiness, and chronic fatigue associated with Parkinson's disease; and other potential indications, such as attention deficit hyperactivity disorder and cognitive disorders, which include schizophrenia. In addition, Athersys, Inc., through its product co-development collaboration with Angiotech Pharmaceuticals, Inc., develops MultiStem for the treatment of damage caused by myocardial infarction and peripheral vascular disease, as well as for a range of disease indications, including ischemic injury and cardiovascular disease, certain neurological diseases, autoimmune diseases, transplant support, and various orphan disease indications. The company was founded in 1995 and is based in Cleveland, Ohio.
(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price 1.84
Volume 508843
Volume Avg (mio) 1.21
52 Week High 2.63
52 Week Low 1.02
PE (group average) N/A
EPS Year -0.26
EPS change Q/Q 0%
EPS change Q/Q Yr ago 0%
EPS change Q/Q next Q est -100%
EPS change Y/Y 0%
REV change Q/Q 0%
REV change Q/Q Yr ago 0%
EPS next Q est -0.07
EPS next Y est -0.30
Divident Annual 0.00
Dividend Yield 0%